UK Oncology Forum

Dear Colleague

Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused.

However – the UK Oncology Forum Faculty is excited to inform you that the meeting has been replaced with a new and very interesting Rapid Diagnostic Services Session, chaired by Dr Saoirse Dolly.

The UK Oncology forum is proud to showcase this inaugural meeting – highlighting the Rapid Diagnostic Services (RDS) for patients with non-site specific symptoms (NSS). Patients with NSS (such as weight loss, fatigue or pain) generally do not fit the standard two week rule (2WW) referral criteria and often bounce around systems and take longer to get diagnosed and treated.

Rapid Diagnostic Clinics (RDCs) provide a NSS 2WW referral route. These are being expanded across the Country with the aim of providing personalised, coordinated diagnostics to facilitate earlier cancer diagnosis and fast-track care. As well as reducing geographic differences in access to diagnostics. This session aims to bring primary care, diagnosticians, oncologists, radiologists and nurse practitioners together to share experiences in the development of the RDS and combine thinking on future developments and innovation.

Potential themes include:
1. RDS overview
RDC referral processes, filter function tests, pathway, alignment with cancer waiting times.
Clinical outcomes (present SEL RDC paper) with a focus on elderly, medically complex patients and mental health.
2. The RDS/re-direct
The vision – one referral, fluidity of care and improved patient journey. Process of re-directing patients between NSS and site specific (SS) pathways.
Options of front and back end redirects from other pathways
Present SEL data on volume of re-referrals from SS 2WW pathways and evaluation of the SEL lower GI back end pathway
Different models – ? involve greater manchester team where they use the upfront re-directs. Ernie on the AOS focused RDC model
3. Sustainability and service expansion
Overcoming health inequalities, NHSE typologies, workforce, financial effectiveness of the service
4. Innovation
Research opportunities, development, clinical trials

The session will take place Thursday 16th June 10:30hrs – 11:45hrs to register for the UK Oncology Forum (which has FREE registration and is CME accredited) please go to:
www.oncology-forum.co.uk/register

Best wishes
The UK Oncology Forum
PS please feel free to share with your colleagues

Latest News

By Caoimhe Keenan on 6th February 2026

Improving Data Collection Quality and Completeness for Systemic Anti-Cancer Therapy (SACT) in Prostate Cancer – Upcoming Webinar

Join the National Prostate Cancer Audit (NPCA) and National Cancer Audit Collaborating Centre (NATCAN) for our next quality improvement webinar on Thursday 19th March 2026 at 09:00 am. Bringing together data managers, clinicians, allied healthcare professionals, and other relevant stakeholders,…

Read article
By BOPA Research Subcommittee on 4th February 2026

Abstract Booklet for the 28th Annual BOPA conference 2025

We’re delighted to share that the BOPA abstracts presented at the 28th Annual BOPA Conference have now been published in the Journal of Oncology Pharmacy Practice. Huge congratulations to everyone…

Read article
By Joseph Williams on 4th February 2026

BOPA welcomes the National Cancer Plan and highlights the essential role of cancer pharmacy professionals in delivering world‑class cancer care

BOPA welcomes the National Cancer Plan and highlights the essential role of cancer pharmacy professionals in delivering world‑class cancer care – The National Cancer Plan for England: delivering world class…

Read article
By BOPA on 22nd January 2026

Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students

Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students   Through an open letter published on its website, the UK Pharmacy Professional Leadership Advisory Board is inviting…

Read article